Wolfe Research Assumes argenx SE (ARGX) at Outperform
- Wall St rises on Alphabet boost, payrolls data in focus
- Can S&P 500 rally without the Magnificent 7 leading the way? 'Easy' says BofA
- Analysts remain cautious on Chewy as shares drop 10% weak guidance
- AI sentiment toward Google seen improving rapidly after Gemini launch; Shares gain
- Yen roars, bonds flinch as Japan teases rates shift
Wolfe Research analyst Andrew Galler assumes coverage on argenx SE (NASDAQ: ARGX) with a Outperform rating.
The analyst comments "In this deck, we discuss key investor debates such as efgartigimod's position in the FcRn pecking order, the approvability and launch expectations for efgartigimod in gMG, and expectations for ITP and PV."
Shares of argenx SE closed at $309.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts First Industrial Realty Trust (FR) at Equal Weight
- UBS Starts Fulgent Genetics (FLGT) at Neutral
- Wells Fargo Starts Match Group (MTCH) at Equal Weight
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!